OpenVSafe by OpenVAERS
Search V-safe

6HV-99055-45713

2 vaccinations 5 coded responses 11 check-ins 5 free-text entries 4 call cases
Sex
Female
Age at first dose
56-60
ZIP prefix
949 / CA
Registered
2021-01-30
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-29
    Dose 1 — Moderna
  2. 2021-01-27
    Dose 2 — Moderna
  3. 2021-01-30
    Registered in v-safe
  4. 2021-01-30
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  5. 2021-02-01
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  6. 2021-02-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  7. 2021-02-03
    Health check-in — day 7, dose 2
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  8. 2021-02-10
    Survey response — day 14, dose 2
    MedDRA: Rash — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: bad rash on hands
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-02-10
    Report sent to call center — day 14, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  10. 2021-02-17
    Survey response — day 21, dose 2
    MedDRA: Fatigue, Office visit, Pruritus, Rash — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Symptoms: Major and expanding diagnosed uticaria rash on torso and extremities. Fatigue due to histamine reaction. Acuity varies throuhout the day and based on activities. Signifcant itching, especially on hands and feet. · Healthcare visit (other): dermatologist visit
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-02-17
    Report sent to call center — day 21, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  12. 2021-02-24
    Survey response — day 28, dose 2
    MedDRA: Hypersensitivity, Urticaria — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: allergic reaction doagnosed as uticaria on extremities and torso. Extensive spread requiring prescription anti histamines amd cortisone cream
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-02-24
    Report sent to call center — day 28, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  14. 2021-03-03
    Survey response — day 35, dose 2
    MedDRA: Rash — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: previously reportrd itocaria rash symptoms are reduced. Still taking daily prescribed course of hydroxazine
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-03-03
    Report sent to call center — day 35, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  16. 2021-03-10
    Health check-in — day 42, dose 2
    Feeling: Fair
    Adult check-in
  17. 2021-04-28
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-07-21
  19. 2021-07-30
    Survey response — 6 months, dose 2
    MedDRA: Fatigue, Nasopharyngitis — Feeling: Good · Be unable to work or attend school
    Free text: jead cold amd fatigue
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  20. 2021-11-08

Vaccinations

DoseDateManufacturerCo-administered
12020-12-29Moderna
22021-01-27Moderna

Call center

4 call center cases

4 unsuccessful

2 waits over 3 months for a first call

See the call center timeline

Free text

Release 4 — day 14, dose 2

2021-02-10

Symptoms: bad rash on hands

Release 4 — day 21, dose 2

2021-02-17

Symptoms: Major and expanding diagnosed uticaria rash on torso and extremities. Fatigue due to histamine reaction. Acuity varies throuhout the day and based on activities. Signifcant itching, especially on hands and feet.
Healthcare visit (other): dermatologist visit

Release 4 — day 28, dose 2

2021-02-24

Symptoms: allergic reaction doagnosed as uticaria on extremities and torso. Extensive spread requiring prescription anti histamines amd cortisone cream

Release 5 — day 35, dose 2

2021-03-03

Symptoms: previously reportrd itocaria rash symptoms are reduced. Still taking daily prescribed course of hydroxazine

Release 9 — 6 months, dose 2

2021-07-30

Symptoms: jead cold amd fatigue

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDHypersensitivity ✓ ✓ ✓
SDNasopharyngitis ✓ · ✓
SDPruritus ✓ ✓ ✓
SDRash ✓ ✓ ✓
SDUrticaria ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release